Usefulness of Interferon-Gamma Release Assay for Diagnosis of Tuberculous Fistulae in Ano.
10.4174/jkss.2011.80.3.189
- Author:
Soung Ho KIM
1
;
Do Yeon HWANG
;
Seok Gyu SONG
;
Hyeok Jin KWON
;
Sun Yeon CHO
;
Duk Hoon PARK
;
Jung Dal LEE
;
Jong Kyun LEE
Author Information
1. Department of Proctology, Seoul Song Do Colorectal Hospital, Seoul, Korea. tieman@lycos.co.kr
- Publication Type:Original Article
- Keywords:
Tuberculous anal fistula;
Interferon-gamma;
Granuloma
- MeSH:
Diagnosis*;
Drug Therapy;
Fistula*;
Granuloma;
Humans;
Interferon-gamma;
Interferon-gamma Release Tests*;
Rectal Fistula;
Retrospective Studies;
Sensitivity and Specificity;
Tuberculosis;
Tuberculosis, Pulmonary;
Victoria
- From:Journal of the Korean Surgical Society
2011;80(3):189-193
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Interferon gamma release assays (QuantiFERON-TB Gold in Tube test [QFT-GIT]); Cellestis Limited, Victoria, Australia) have been studied for diagnosing pulmonary tuberculosis (TB) or latent TB but there have been no reports on the usefulness of this assay in diagnosing tuberculous anal fistula in actual clinical practices. In this study, we evaluated its diagnostic usefulness in patients with suspected tuberculous anal fistula. METHODS: We conducted a retrospective analysis of 119 patients with suspected tuberculous anorectal fistula from May 2007 to May 2009. Diagnosis of tuberculous fistula was concluded by identification of acid-fast bacilli, typical caseating granuloma and successful clinical response to anti-TB chemotherapy. All patients underwent the QFT-GIT and all patients diagnosed with tuberculous anal fistula were analyzed. RESULTS: Of the 119 patients with suspected TB fistula, 51 (43%) patients were classified as having TB fistula, including 31 with confirmed tuberculosis and 20 with probable tuberculosis, and other 68 (57%) were classified as not having tuberculosis. Among the 51 patients with TB fistula, Chronic caseating granuloma, acid-fast bacilli stain, and successful clinical response to anti-TB treatment were positive in 27 (52.9%), 4 (7.8%), and 20 (39.2%), respectively. Of the 51 with TB fistula, 44 had positive QFT-GIT results and 7 had negative results. The sensitivity and specificity of the assay were 86% and 85%, and positive predictive value (PPV) and negative predictive value (NPV) were 81% and 89%, respectively. CONCLUSION: QFT-GIT is a simple, sensitive, and specific method for the diagnosis of clinically highly suspected TB fistula.
